|
1
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu Y, Mao Q and Liang X: Targeting the
MicroRNA-490-3p-ATG4B-Autophagy axis relieves myocardial injury in
ischemia reperfusion. J Cardiovasc Transl Res. 14:173–183. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gulei D, Raduly L, Broseghini E, Ferracin
M and Berindan-Neagoe I: The extensive role of miR-155 in malignant
and non-malignant diseases. Mol Aspects Med. 70:33–56. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Y, Yuan MH, Wu HT, Chen WJ, Zhang ML,
Ye QQ, Liu J and Zhang GJ: MicroRNA-488 inhibits proliferation and
motility of tumor cells via downregulating FSCN1, modulated by
Notch3 in breast carcinomas. Cell Death Dis. 11:9122020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang H, Chen W, Jin M, Hou L, Chen X,
Zhang R, Zhang J and Zhu J: CircSLC3A2 functions as an oncogenic
factor in hepatocellular carcinoma by sponging miR-490-3p and
regulating PPM1F expression. Mol Cancer. 17:1652018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Z, Ma T, Huang C, Hu T and Li J: The
pivotal role of microRNA-155 in the control of cancer. J Cell
Physiol. 229:545–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang LY, Liu M, Li X and Tang H:
miR-490-3p modulates cell growth and epithelial to mesenchymal
transition of hepatocellular carcinoma cells by targeting
endoplasmic reticulum-Golgi intermediate compartment protein 3
(ERGIC3). J Biol Chem. 288:4035–4047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsui M and Corey DR: Non-coding RNAs as
drug targets. Nat Rev Drug Discov. 16:167–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Bari M, Bevilacqua V, De Jaco A, Laneve
P, Piovesana R, Trobiani L, Talora C, Caffarelli E and Tata AM:
miR-34a-5p mediates cross-talk between M2 muscarinic receptors and
Notch-1/EGFR pathways in U87MG glioblastoma cells: Implication in
cell proliferation. Int J Mol Sci. 19:16312018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cristofaro I, Spinello Z, Matera C, Fiore
M, Conti L, De Amici M, Dallanoce C and Tata AM: Activation of M2
muscarinic acetylcholine receptors by a hybrid agonist enhances
cytotoxic effects in GB7 glioblastoma cancer stem cells. Neurochem
Int. 118:52–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vinchure OS, Sharma V, Tabasum S, Ghosh S,
Singh RP, Sarkar C and Kulshreshtha R: Polycomb complex mediated
epigenetic reprogramming alters TGF-β signaling via a novel
EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT
potential in glioblastomas. Int J Cancer. 145:1254–1269. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han Y, Chen J, Zhao X, Liang C, Wang Y,
Sun L, Jiang Z, Zhang Z, Yang R, Chen J, et al: MicroRNA expression
signatures of bladder cancer revealed by deep sequencing. PLoS One.
6:e182862011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hamfjord J, Stangeland AM, Hughes T,
Skrede ML, Tveit KM, Ikdahl T and Kure EH: Differential expression
of miRNAs in colorectal cancer: Comparison of paired tumor tissue
and adjacent normal mucosa using high-throughput sequencing. PLoS
One. 7:e341502012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv Y, Yang H, Ma X and Wu G:
Strand-specific miR-28-3p and miR-28-5p have differential effects
on nasopharyngeal cancer cells proliferation, apoptosis, migration
and invasion. Cancer Cell Int. 19:1872019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu L, Zhang M, Qi L, Zu X, Li Y, Liu L,
Chen M, Li Y, He W, Hu X, et al: ERα-mediated alterations in
circ_0023642 and miR-490-5p signaling suppress bladder cancer
invasion. Cell Death Dis. 10:6352019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Feng Q, Wei X and Yu Y: MicroRNA-490
regulates lung cancer metastasis by targeting poly r(C)-binding
protein 1. Tumour Biol. 37:15221–15228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang M, Wang X, Tan J, Zhao M, Lian L and
Zhang W: Poly r(C) binding protein (PCBP) 1 is a negative regulator
of thyroid carcinoma. Am J Transl Res. 8:3567–3573. 2016.PubMed/NCBI
|
|
20
|
Jiang Y, Luan Y, Chang H and Chen G: The
diagnostic and prognostic value of plasma microRNA-125b-5p in
patients with multiple myeloma. Oncol Lett. 16:4001–4007.
2018.PubMed/NCBI
|
|
21
|
Xia S, Zhao Z, Xie F, He J and Li H: Poly
r(C) binding protein is post-transcriptionally repressed by
miR-490-3p to potentiate squamous cell carcinoma. Tumour Biol.
37:14773–14778. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, He B, Xu T, Pan Y, Hu X, Chen X and
Wang S: miR-490-3p functions as a tumor suppressor by inhibiting
oncogene VDAC1 expression in colorectal cancer. J Cancer.
9:1218–1230. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng K, Zhou X, Yu J, Li Q, Wang H, Li M,
Shao Z, Zhang F, Luo Y, Shen Z, et al: Epigenetic silencing of
miR-490-3p promotes development of an aggressive colorectal cancer
phenotype through activation of the Wnt/β-catenin signaling
pathway. Cancer Lett. 376:178–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu X, Chen R, Li Z, Huang N, Wu X, Li S,
Li Y and Wu S: MicroRNA-490-3p inhibits colorectal cancer
metastasis by targeting TGFβR1. BMC Cancer. 15:10232015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo M and Liang C: LncRNA LINC00483
promotes gastric cancer development through regulating MAPK1
expression by sponging miR-490-3p. Biol Res. 53:142020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou B, Wang Y, Jiang J, Jiang H, Song J,
Han T, Shi J and Qiao H: The long noncoding RNA colon
cancer-associated transcript-1/miR-490 axis regulates gastric
cancer cell migration by targeting hnRNPA1. IUBMB Life. 68:201–210.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen J, Xiao Z, Wu WK, Wang MH, To KF,
Chen Y, Yang W, Li MS, Shin VY, Tong JH, et al: Epigenetic
silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1
to promote Helicobacter pylori-induced gastric carcinogenesis.
Cancer Res. 75:754–765. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leng K, Xu Y, Kang P, Qin W, Cai H, Wang
H, Ji D, Jiang X, Li J, Li Z, et al: Akirin2 is modulated by
miR-490-3p and facilitates angiogenesis in cholangiocarcinoma
through the IL-6/STAT3/VEGFA signaling pathway. Cell Death Dis.
10:2622019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang ZY, Gao XH, Ma MY, Zhao CL, Zhang YL
and Guo SS: CircRNA_101237 promotes NSCLC progression via the
miRNA-490-3p/MAPK1 axis. Sci Rep. 10:90242020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong Z, Liu H and Zhao G: Long noncoding
RNA SNHG6 promotes proliferation and inhibits apoptosis in
Non-small cell lung cancer cells by regulating miR-490-3p/RSF1
Axis. Cancer Biother Radiopharm. 35:351–361. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gu H, Yang T, Fu S, Chen X, Guo L and Ni
Y: MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells
by targeting CCND1. Biochem Biophys Res Commun. 444:104–108. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan H and Zhang YS: MiR-490-3p modulates
the progression of prostate cancer through regulating histone
deacetylase 2. Eur Rev Med Pharmacol Sci. 23:539–546.
2019.PubMed/NCBI
|
|
33
|
Liu Y, Li L, Wang X, Wang P and Wang Z:
LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian
epithelial carcinoma cell proliferation. J Ovarian Res. 13:602020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mu Y, Li N and Cui YL: The lncRNA CCAT1
upregulates TGFβR1 via sponging miR-490-3p to promote TGFβ1-induced
EMT of ovarian cancer cells. Cancer Cell Int. 18:1452018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang LL, Sun KX, Wu DD, Xiu YL, Chen X,
Chen S, Zong ZH, Sang XB, Liu Y and Zhao Y: DLEU1 contributes to
ovarian carcinoma tumourigenesis and development by interacting
with miR-490-3p and altering CDK1 expression. J Cell Mol Med.
21:3055–3065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tian J, Xu YY, Li L and Hao Q: miR-490-3p
sensitizes ovarian cancer cells to cisplatin by directly targeting
ABCC2. Am J Transl Res. 9:1127–1138. 2017.PubMed/NCBI
|
|
37
|
Chen S, Chen X, Xiu YL, Sun KX and Zhao Y:
MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial
carcinoma tumorigenesis and progression. Cancer Lett. 362:122–130.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang G, Ma A, Jin Y, Pan G and Wang C:
LncRNA SNHG16 induced by TFAP2A modulates glycolysis and
proliferation of endometrial carcinoma through miR-490-3p/HK2 axis.
Am J Transl Res. 11:7137–7145. 2019.PubMed/NCBI
|
|
39
|
Shao W, Li Y, Chen F, Jia H, Jia J and Fu
Y: Long non-coding RNA DLEU1 contributes to the development of
endometrial cancer by sponging miR-490 to regulate SP1 expression.
Pharmazie. 73:379–385. 2018.PubMed/NCBI
|
|
40
|
Sun KX, Chen Y, Chen S, Liu BL, Feng MX,
Zong ZH and Zhao Y: The correlation between microRNA490-3p and TGFα
in endometrial carcinoma tumorigenesis and progression. Oncotarget.
7:9236–9249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao L and Zheng XY: MicroRNA-490 inhibits
tumorigenesis and progression in breast cancer. Onco Targets Ther.
9:4505–4516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jia Z, Liu Y, Gao Q, Han Y, Zhang G, Xu S,
Cheng K and Zou W: miR-490-3p inhibits the growth and invasiveness
in triple-negative breast cancer by repressing the expression of
TNKS2. Gene. 593:41–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu W, Xu G, Liu H and Li T:
MicroRNA-490-3p regulates cell proliferation and apoptosis by
targeting HMGA2 in osteosarcoma. FEBS Lett. 589((20 Pt B)):
3148–3153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang C, Chen F, Fan Z, Yao C and Xiao L:
lncRNA CCAT1/miR-490-3p/MAPK1/c-Myc positive feedback loop drives
progression of acute myeloid leukaemia. J Biochem. 167:379–388.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang H, Bao J, Zhao S, Huo Z and Li B:
MicroRNA-490-3p suppresses hepatocellular carcinoma cell
proliferation and migration by targeting the aurora kinase A gene
(AURKA). Arch Med Sci. 16:395–406. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ding S, Jin Y, Hao Q, Kang Y and Ma R:
LncRNA BCYRN1/miR-490-3p/POU3F2, served as a ceRNA network, is
connected with worse survival rate of hepatocellular carcinoma
patients and promotes tumor cell growth and metastasis. Cancer Cell
Int. 20:62020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen W, Li K, Zhu K, Yan R, Cai QC, Li WH
and Dang CX: RP11-81H3.2 acts as an oncogene via microRNA-490-3p
inhibition and consequential Tankyrase 2 Up-Regulation in
hepatocellular carcinoma. Dig Dis Sci. 65:2949–2958. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dai W, Dai JL, Tang MH, Ye MS and Fang S:
lncRNA-SNHG15 accelerates the development of hepatocellular
carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
World J Gastroenterol. 25:5789–5799. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yu Y, Cai O, Wu P and Tan S: miR-490-5p
inhibits the stemness of hepatocellular carcinoma cells by
targeting ECT2. J Cell Biochem. 120:967–976. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cai H, Hu B, Ji L, Ruan X and Zheng Z:
Hsa_circ_0103809 promotes cell proliferation and inhibits apoptosis
in hepatocellular carcinoma by targeting miR-490-5p/SOX2 signaling
pathway. Am J Transl Res. 10:1690–1702. 2018.PubMed/NCBI
|
|
51
|
Fang ZQ, Li MC, Zhang YQ and Liu XG:
miR-490-5p inhibits the metastasis of hepatocellular carcinoma by
down-regulating E2F2 and ECT2. J Cell Biochem. 119:8317–8324. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ou Y, He J and Liu Y: miR-490-3p inhibits
autophagy via targeting ATG7 in hepatocellular carcinoma. IUBMB
Life. 70:468–478. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen W, Ye L, Wen D and Chen F: miR-490-5p
inhibits hepatocellular carcinoma cell proliferation, migration and
invasion by directly regulating ROBO1. Pathol Oncol Res. 25:1–9.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xu B, Xu T, Liu H, Min Q, Wang S and Song
Q: miR-490-5p suppresses cell proliferation and invasion by
targeting BUB1 in hepatocellular carcinoma cells. Pharmacology.
100:269–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dou C, Sun L, Jin X, Han M, Zhang B and Li
T: Long non-coding RNA colon cancer-associated transcript 1
functions as a competing endogenous RNA to regulate
cyclin-dependent kinase 1 expression by sponging miR-490-3p in
hepatocellular carcinoma progression. Tumour Biol.
39:10104283176975722017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pan Z, Lin J, Wu D, He X, Wang W, Hu X,
Zhang L and Wang M: Hsa_circ_0006948 enhances cancer progression
and epithelial-mesenchymal transition through the miR-490-3p/HMGA2
axis in esophageal squamous cell carcinoma. Aging (Albany NY).
11:11937–11954. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li FZ and Zang WQ: Knockdown of
lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal
squamous cell carcinoma cells. World J Gastroenterol. 25:6299–6310.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zabihula B, Yiliyasi M, Lu Y and Salai A:
MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of
ESCC cells via MAPK1 downregulation. Oncol Lett. 18:3170–3176.
2019.PubMed/NCBI
|
|
59
|
Kang NN, Ge SL, Zhang RQ, Huang YL, Liu SD
and Wu KM: MiR-490-3p inhibited the proliferation and metastasis of
esophageal squamous cell carcinoma by targeting HMGA2. Eur Rev Med
Pharmacol Sci. 22:8298–8305. 2018.PubMed/NCBI
|
|
60
|
Zhang F, Wu A, Wang Y and Liu J:
miR-490-3p functions as a tumor suppressor in glioma by inhibiting
high-mobility group AT-hook 2 expression. Exp Ther Med. 18:664–670.
2019.PubMed/NCBI
|
|
61
|
Zhao L, Tang X, Luo R, Duan J, Wang Y and
Yang B: MicroRNA-490-5P Targets CCND1 to suppress cellular
proliferation in glioma cells and tissue through cell cycle arrest.
Curr Neurovasc Res. 15:246–255. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lan G, Yang L, Xie X, Peng L and Wang Y:
MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in
human bladder cancer. Arch Med Sci. 11:561–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li S, Xu X, Xu X, Hu Z, Wu J, Zhu Y, Chen
H, Mao Y, Lin Y, Luo J, et al: MicroRNA-490-5p inhibits
proliferation of bladder cancer by targeting c-Fos. Biochem Biophys
Res Commun. 441:976–981. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chen K, Zeng J, Tang K, Xiao H, Hu J,
Huang C, Yao W, Yu G, Xiao W, Guan W, et al: MiR-490-5p suppresses
tumour growth in renal cell carcinoma through targeting PIK3CA.
Biol Cell. 108:41–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang J, Zhang X, Yao H, Le Y, Zhou W, Li
J, Lu L, Chen M and Li X: miR-490-5p functions as tumor suppressor
in childhood neuroblastoma by targeting MYEOV. Hum Cell.
33:261–271. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Abdeyrim A, Cheng X, Lian M and Tan Y:
miR4905p regulates the proliferation, migration, invasion and
epithelial-mesenchymal transition of pharyngolaryngeal cancer cells
by targeting mitogen-activated protein kinase kinasekinase 9. Int J
Mol Med. 44:240–252. 2019.PubMed/NCBI
|
|
67
|
Wu M, Tu T, Huang Y and Cao Y: Suppression
subtractive hybridization identified differentially expressed genes
in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene.
BMC Cancer. 13:442013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhao Q, Wu M, Zheng X, Yang L, Zhang Z, Li
X and Chen J: ERGIC3 silencing additively enhances the growth
inhibition of BFA on lung adenocarcinoma cells. Curr Cancer Drug
Targets. 20:67–75. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Buchan JR and Parker R: Molecular biology.
The two faces of miRNA. Science. 318:1877–1878. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Ansa-Addo EA, Huang HC, Riesenberg B,
Iamsawat S, Borucki D, Nelson MH, Nam JH, Chung D, Paulos CM, Liu
B, et al: RNA binding protein PCBP1 is an intracellular immune
checkpoint for shaping T cell responses in cancer immunity. Sci
Adv. 6:eaaz38652020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang MP, Zhang WS, Tan J, Zhao MH, Lian
LJ and Cai J: Poly r(C) binding protein (PCBP) 1 expression is
regulated by the E3 ligase UBE4A in thyroid carcinoma. Biosci Rep.
37:BSR201701142017. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Jones SA, Scheller J and Rose-John S:
Therapeutic strategies for the clinical blockade of IL-6/gp130
signaling. J Clin Invest. 121:3375–3383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hino S, Michiue T, Asashima M and Kikuchi
A: Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1
and is essential for Wnt-3a-induced accumulation of beta-catenin. J
Biol Chem. 278:14066–14073. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mariotti L, Templeton CM, Ranes M,
Paracuellos P, Cronin N, Beuron F, Morris E and Guettler S:
Tankyrase requires SAM domain-dependent polymerization to support
Wnt-β-catenin signaling. Mol Cell. 63:498–513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kozma SC and Thomas G: p70s6k/p85s6k:
Mechanism of activation and role in mitogenesis. Semin Cancer Biol.
5:255–260. 1994.PubMed/NCBI
|
|
76
|
Inoki K, Ouyang H, Zhu T, Lindvall C, Wang
Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, et al: TSC2
integrates Wnt and energy signals via a coordinated phosphorylation
by AMPK and GSK3 to regulate cell growth. Cell. 126:955–968. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhao M, Mishra L and Deng CX: The role of
TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 14:111–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Feng XH, Lin X and Derynck R: Smad2, Smad3
and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in
response to TGF-beta. EMBO J. 19:5178–5193. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Duda P, Akula SM, Abrams SL, Steelman LS,
Martelli AM, Cocco L, Ratti S, Candido S, Libra M, Montalto G, et
al: Targeting GSK3 and associated signaling pathways involved in
cancer. Cells. 9:11102020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Shimura T: Acquired radioresistance of
cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat
Res. 52:539–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Vinchure OS and Kulshreshtha R: miR-490: A
potential biomarker and therapeutic target in cancer and other
diseases. J Cell Physiol. 236:3178–3193. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhang X, Di C, Chen Y, Wang J, Su R, Huang
G, Xu C, Chen X, Long F, Yang H and Zhang H: Multilevel regulation
and molecular mechanism of poly (rC)-binding protein 1 in cancer.
FASEB J. 34:15647–15658. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Tripathi V, Sixt KM, Gao S, Xu X, Huang J,
Weigert R, Zhou M and Zhang YE: Direct regulation of alternative
splicing by SMAD3 through PCBP1 Is essential to the tumor-promoting
role of TGF-β. Mol Cell. 64:549–564. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lin QH, Zhang KD, Duan HX, Liu MX, Wei WL
and Cao Y: ERGIC3, which is regulated by miR-203a, is a potential
biomarker for non-small cell lung cancer. Cancer Sci.
106:1463–1473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Tao W, Sun W, Zhu H and Zhang J: Knockdown
of long non-coding RNA TP73-AS1 suppresses triple negative breast
cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1
axis. Biochem Biophys Res Commun. 504:629–634. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Fan H, Yuan J and Li X, Ma Y, Wang X, Xu B
and Li X: LncRNA LINC00173 enhances triple-negative breast cancer
progression by suppressing miR-490-3p expression. Biomed
Pharmacother. 125:1099872020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhang C, Ma MH, Liang Y, Wu KZ and Dai DQ:
Novel long non-coding RNA LINC02532 promotes gastric cancer cell
proliferation, migration, and invasion in vitro. World J
Gastrointest Oncol. 11:91–101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Li MF, Zeng JJ, Pan AP, Lin YH, Lin HS,
Zhang RZ, Yang L, Zhang Y, Dang YW and Chen G: Investigation of
miR-490-3p expression in hepatocellular carcinoma based on reverse
transcription-polymerase chain reaction (RT-qPCR) and a
meta-analysis of 749 cases. Med Sci Monit. 24:4914–4925. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lai CH, Liang XZ, Liang XY, Ma SJ, Li JG,
Shi MF, Zhu X, Lan HH and Zeng JH: Study on miRNAs in Pan-cancer of
the digestive tract based on the Illumina HiSeq system data
sequencing. Biomed Res Int. 2019:80161202019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tang B, Liu C, Zhang QM and Ni M:
Decreased expression of miR-490-3p in osteosarcoma and its clinical
significance. Eur Rev Med Pharmacol Sci. 21:246–251.
2017.PubMed/NCBI
|
|
91
|
Qu M, Li L and Zheng WC: Reduced
miR-490-3p expression is associated with poor prognosis of
Helicobacter pylori induced gastric cancer. Eur Rev Med
Pharmacol Sci. 21:3384–3388. 2017.PubMed/NCBI
|
|
92
|
Yang H, Zhang L, Wang XD, Huang ML, Lin P,
Pang YY, Feng ZB and Chen G: Potential targets and clinical value
of miR-490-5p in hepatocellular carcinoma: A study based on TCGA,
qRT-PCR and bioinformatics analyses. Int J Clin Exp Pathol.
11:1123–1134. 2018.PubMed/NCBI
|
|
93
|
Xu X, Wu X, Wu S, Jiang Q, Liu H, Chen R
and Sun Y: Study on miR-490-5p and miR-363 as novel biomarkers for
the diagnosis of colorectal cancer. Zhonghua Wei Chang Wai Ke Za
Zhi. 17:45–50. 2014.(In Chinese). PubMed/NCBI
|
|
94
|
Chen S, Chen X, Xiu YL, Sun KX, Zong ZH
and Zhao Y: MicroRNA 490-3P enhances the drug-resistance of human
ovarian cancer cells. J Ovarian Res. 7:842014. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Orom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Jiang Y, Jiang YY, Xie JJ, Mayakonda A,
Hazawa M, Chen L, Xiao JF, Li CQ, Huang ML, Ding LW, et al:
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2
promotes squamous cancer progression. Nat Commun. 9:36192018.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Xiong L, Zhen S, Yu Q and Gong Z: HCV-E2
inhibits hepatocellular carcinoma metastasis by stimulating mast
cells to secrete exosomal shuttle microRNAs. Oncol Lett.
14:2141–2146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ding L, Ning J, Wang Q, Lu B and Ke H:
Sevoflurane improves nerve regeneration and repair of neurological
deficit in brain damage rats via microRNA-490-5p/CDK1 axis. Life
Sci. 271:1191112021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Bai J, Yeh S, Qiu X, Hu L, Zeng J, Cai Y,
Zuo L, Li G, Yang G and Chang C: TR4 nuclear receptor promotes
clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM)
formation and metastasis via altering the miR490-3p/vimentin
signals. Oncogene. 37:5901–5912. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wang B, Yin M, Cheng C, Jiang H, Jiang K,
Shen Z, Ye Y and Wang S: Decreased expression of miR4903p in
colorectal cancer predicts poor prognosis and promotes cell
proliferation and invasion by targeting RAB14. Int J Oncol.
53:1247–1256. 2018.PubMed/NCBI
|
|
102
|
Zhang C, Wang W, Lin J, Xiao J and Tian Y:
lncRNA CCAT1 promotes bladder cancer cell proliferation, migration
and invasion. Int Braz J Urol. 45:549–559. 2019. View Article : Google Scholar : PubMed/NCBI
|
